Fredun Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 26, 2026	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Market Capitalization	13,218	8,072	3,142	3,371	3,572	4,057
Market Cap Growth	303.40%	156.94%	-6.80%	-5.63%	-11.97%	119.38%
Enterprise Value	14,793	9,695	4,496	3,993	4,419	4,511
Last Close Price	2397.80	1671.80	668.17	716.23	775.47	912.61
PE Ratio	39.16	24.75	15.92	21.58	33.05	64.04
PS Ratio	2.07	1.26	0.69	0.97	1.30	1.81
PB Ratio	4.75	2.90	2.22	2.78	3.71	5.96
P/TBV Ratio	4.76	2.91	2.23	2.79	3.72	5.97
P/FCF Ratio	31.73	19.37	-	-	-	-
P/OCF Ratio	11.47	7.00	-	-	-	-
EV/Sales Ratio	2.31	1.52	0.99	1.15	1.61	2.01
EV/EBITDA Ratio	15.65	10.26	8.38	10.50	15.82	32.51
EV/EBIT Ratio	17.14	11.24	9.23	11.64	17.56	38.42
EV/FCF Ratio	35.50	23.27	-	-	-	-
Debt / Equity Ratio	0.80	0.80	1.19	0.87	0.90	0.89
Debt / EBITDA Ratio	2.35	2.35	3.14	2.77	3.10	4.37
Debt / FCF Ratio	5.34	5.34	-	-	-	-
Net Debt / Equity Ratio	0.57	0.57	1.15	0.85	0.86	0.86
Net Debt / EBITDA Ratio	1.67	1.67	3.03	2.72	2.98	4.22
Net Debt / FCF Ratio	3.78	3.78	-4.62	-12.80	-3.48	-8.78
Asset Turnover	1.13	1.13	1.14	1.23	1.24	1.29
Inventory Turnover	1.84	1.84	1.69	1.70	2.23	3.23
Quick Ratio	0.53	0.53	0.56	0.40	0.27	1.25
Current Ratio	1.68	1.68	1.30	1.54	1.55	2.07
Return on Equity (ROE)	15.55%	15.55%	15.02%	14.34%	13.14%	11.40%
Return on Assets (ROA)	9.55%	9.55%	7.66%	7.59%	7.08%	4.21%
Return on Invested Capital (ROIC)	15.87%	16.20%	13.23%	12.35%	10.15%	8.07%
Return on Capital Employed (ROCE)	25.00%	25.00%	30.60%	24.40%	21.40%	10.40%
Earnings Yield	2.47%	4.04%	6.28%	4.63%	3.03%	1.56%
FCF Yield	3.15%	5.16%	-11.20%	-2.40%	-6.69%	-1.64%
Dividend Yield	0.03%	-	0.10%	0.10%	0.09%	0.08%
Buyback Yield / Dilution	-14.77%	-14.77%	-	-3.66%	-7.85%	-4.06%
Total Shareholder Return	-14.74%	-14.77%	0.10%	-3.56%	-7.76%	-3.98%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.